淋病治療薬市場は、2022年から2027年の間に5億668万米ドル成長すると予測されており、予測期間中にCAGRは5.47%で加速します。淋病治療薬市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
	このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。この市場は、淋病の有病率の上昇、淋病に関連する高リスクの合併症、および新しい診断検査の使用の増加によって牽引されています。
	この調査は、抗生物質耐性と戦うための政府の取り組みの高まりが、今後数年間の淋病治療薬市場の成長を促進する主な理由の1つであることを特定しています。また、淋病を予防するためのワクチンの出現と、迅速なパートナー療法の採用の増加により、市場での相当な需要が増加すると考えられます。
	この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
	このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
								
						目次
						
	Table of Contents
	1 Executive Summary
	
	1.1 Market overview
	Exhibit 01: Executive Summary - Chart on Market Overview
	Exhibit 02: Executive Summary - Data Table on Market Overview
	Exhibit 03: Executive Summary - Chart on Global Market Characteristics
	Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
	Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
	Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy
	Exhibit 07: Executive Summary - Chart on Incremental Growth
	Exhibit 08: Executive Summary - Data Table on Incremental Growth
	Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
	2 Market Landscape
	
	2.1 Market ecosystem
	Exhibit 10: Parent market
	Exhibit 11: Market Characteristics
	3 Market Sizing
	
	3.1 Market definition
	Exhibit 12: Offerings of vendors included in the market definition
	3.2 Market segment analysis
	Exhibit 13: Market segments
	3.3 Market size 2022
	3.4 Market outlook: Forecast for 2022-2027
	Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
	Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
	Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
	Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
	4 Historic Market Size
	
	4.1 Global gonorrhea therapeutics market 2017 - 2021
	Exhibit 18: Historic Market Size - Data Table on global gonorrhea therapeutics market 2017 - 2021 ($ million)
	4.2 Distribution Channel Segment Analysis 2017 - 2021
	Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
	4.3 Therapy Segment Analysis 2017 - 2021
	Exhibit 20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
	4.4 Geography Segment Analysis 2017 - 2021
	Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
	4.5 Country Segment Analysis 2017 - 2021
	Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
	5 Five Forces Analysis
	
	5.1 Five forces summary
	Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
	5.2 Bargaining power of buyers
	Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
	5.3 Bargaining power of suppliers
	Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
	5.4 Threat of new entrants
	Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
	5.5 Threat of substitutes
	Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
	5.6 Threat of rivalry
	Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
	5.7 Market condition
	Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
	6 Market Segmentation by Distribution Channel
	
	6.1 Market segments
	Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
	Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
	6.2 Comparison by Distribution Channel
	Exhibit 32: Chart on Comparison by Distribution Channel
	Exhibit 33: Data Table on Comparison by Distribution Channel
	6.3 Hospital pharmacies - Market size and forecast 2022-2027
	Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
	Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
	Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
	Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
	6.4 Retail pharmacies - Market size and forecast 2022-2027
	Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
	Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
	Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
	Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
	6.5 Online pharmacies - Market size and forecast 2022-2027
	Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
	Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
	Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
	Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
	6.6 Market opportunity by Distribution Channel
	Exhibit 46: Market opportunity by Distribution Channel ($ million)
	Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
	7 Market Segmentation by Therapy
	
	7.1 Market segments
	Exhibit 48: Chart on Therapy - Market share 2022-2027 (%)
	Exhibit 49: Data Table on Therapy - Market share 2022-2027 (%)
	7.2 Comparison by Therapy
	Exhibit 50: Chart on Comparison by Therapy
	Exhibit 51: Data Table on Comparison by Therapy
	7.3 Monotherapy - Market size and forecast 2022-2027
	Exhibit 52: Chart on Monotherapy - Market size and forecast 2022-2027 ($ million)
	Exhibit 53: Data Table on Monotherapy - Market size and forecast 2022-2027 ($ million)
	Exhibit 54: Chart on Monotherapy - Year-over-year growth 2022-2027 (%)
	Exhibit 55: Data Table on Monotherapy - Year-over-year growth 2022-2027 (%)
	7.4 Combination therapy - Market size and forecast 2022-2027
	Exhibit 56: Chart on Combination therapy - Market size and forecast 2022-2027 ($ million)
	Exhibit 57: Data Table on Combination therapy - Market size and forecast 2022-2027 ($ million)
	Exhibit 58: Chart on Combination therapy - Year-over-year growth 2022-2027 (%)
	Exhibit 59: Data Table on Combination therapy - Year-over-year growth 2022-2027 (%)
	7.5 Market opportunity by Therapy
	Exhibit 60: Market opportunity by Therapy ($ million)
	Exhibit 61: Data Table on Market opportunity by Therapy ($ million)
	8 Customer Landscape
	
	8.1 Customer landscape overview
	Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
	9 Geographic Landscape
	
	9.1 Geographic segmentation
	Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
	Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
	9.2 Geographic comparison
	Exhibit 65: Chart on Geographic comparison
	Exhibit 66: Data Table on Geographic comparison
	9.3 North America - Market size and forecast 2022-2027
	Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
	Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
	Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
	Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
	9.4 Europe - Market size and forecast 2022-2027
	Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
	Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
	Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
	Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
	9.5 Asia - Market size and forecast 2022-2027
	Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
	Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
	Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
	Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
	9.6 Rest of World (ROW) - Market size and forecast 2022-2027
	Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
	Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
	Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
	Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
	9.7 US - Market size and forecast 2022-2027
	Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
	Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
	Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
	Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
	9.8 Germany - Market size and forecast 2022-2027
	Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
	Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
	Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
	Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
	9.9 China - Market size and forecast 2022-2027
	Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
	Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
	Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
	Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
	9.10 UK - Market size and forecast 2022-2027
	Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
	Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
	Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
	Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
	9.11 Japan - Market size and forecast 2022-2027
	Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
	Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
	Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
	Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
	9.12 Market opportunity By Geographical Landscape
	Exhibit 103: Market opportunity By Geographical Landscape ($ million)
	Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
	10 Drivers, Challenges, and Trends
	
	10.1 Market drivers
	10.2 Market challenges
	10.3 Impact of drivers and challenges
	Exhibit 105: Impact of drivers and challenges in 2022 and 2027
	10.4 Market trends
	11 Vendor Landscape
	
	11.1 Overview
	11.2 Vendor landscape
	Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
	11.3 Landscape disruption
	Exhibit 107: Overview on factors of disruption
	11.4 Industry risks
	Exhibit 108: Impact of key risks on business
	12 Vendor Analysis
	
	12.1 Vendors covered
	Exhibit 109: Vendors covered
	12.2 Market positioning of vendors
	Exhibit 110: Matrix on vendor position and classification
	12.3 Apotex Inc.
	Exhibit 111: Apotex Inc. - Overview
	Exhibit 112: Apotex Inc. - Product / Service
	Exhibit 113: Apotex Inc. - Key offerings
	12.4 Aurobindo Pharma Ltd.
	Exhibit 114: Aurobindo Pharma Ltd. - Overview
	Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
	Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
	12.5 Bristol Myers Squibb Co.
	Exhibit 117: Bristol Myers Squibb Co. - Overview
	Exhibit 118: Bristol Myers Squibb Co. - Product / Service
	Exhibit 119: Bristol Myers Squibb Co. - Key news
	Exhibit 120: Bristol Myers Squibb Co. - Key offerings
	12.6 Cipla Ltd.
	Exhibit 121: Cipla Ltd. - Overview
	Exhibit 122: Cipla Ltd. - Business segments
	Exhibit 123: Cipla Ltd. - Key news
	Exhibit 124: Cipla Ltd. - Key offerings
	Exhibit 125: Cipla Ltd. - Segment focus
	12.7 Debiopharm International SA
	Exhibit 126: Debiopharm International SA - Overview
	Exhibit 127: Debiopharm International SA - Product / Service
	Exhibit 128: Debiopharm International SA - Key news
	Exhibit 129: Debiopharm International SA - Key offerings
	12.8 Entasis Therapeutics
	Exhibit 130: Entasis Therapeutics - Overview
	Exhibit 131: Entasis Therapeutics - Product / Service
	Exhibit 132: Entasis Therapeutics - Key offerings
	12.9 F. Hoffmann La Roche Ltd.
	Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
	Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
	Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
	Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
	Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus
	12.10 GlaxoSmithKline Plc
	Exhibit 138: GlaxoSmithKline Plc - Overview
	Exhibit 139: GlaxoSmithKline Plc - Business segments
	Exhibit 140: GlaxoSmithKline Plc - Key news
	Exhibit 141: GlaxoSmithKline Plc - Key offerings
	Exhibit 142: GlaxoSmithKline Plc - Segment focus
	12.11 Hikma Pharmaceuticals Plc
	Exhibit 143: Hikma Pharmaceuticals Plc - Overview
	Exhibit 144: Hikma Pharmaceuticals Plc - Business segments
	Exhibit 145: Hikma Pharmaceuticals Plc - Key offerings
	Exhibit 146: Hikma Pharmaceuticals Plc - Segment focus
	12.12 Lupin Ltd.
	Exhibit 147: Lupin Ltd. - Overview
	Exhibit 148: Lupin Ltd. - Product / Service
	Exhibit 149: Lupin Ltd. - Key news
	Exhibit 150: Lupin Ltd. - Key offerings
	12.13 Mayne Pharma Group Ltd.
	Exhibit 151: Mayne Pharma Group Ltd. - Overview
	Exhibit 152: Mayne Pharma Group Ltd. - Business segments
	Exhibit 153: Mayne Pharma Group Ltd. - Key news
	Exhibit 154: Mayne Pharma Group Ltd. - Key offerings
	Exhibit 155: Mayne Pharma Group Ltd. - Segment focus
	12.14 Pfizer Inc.
	Exhibit 156: Pfizer Inc. - Overview
	Exhibit 157: Pfizer Inc. - Product / Service
	Exhibit 158: Pfizer Inc. - Key news
	Exhibit 159: Pfizer Inc. - Key offerings
	12.15 Sun Pharmaceutical Industries Ltd.
	Exhibit 160: Sun Pharmaceutical Industries Ltd. - Overview
	Exhibit 161: Sun Pharmaceutical Industries Ltd. - Product / Service
	Exhibit 162: Sun Pharmaceutical Industries Ltd. - Key offerings
	12.16 Teva Pharmaceutical Industries Ltd.
	Exhibit 163: Teva Pharmaceutical Industries Ltd. - Overview
	Exhibit 164: Teva Pharmaceutical Industries Ltd. - Business segments
	Exhibit 165: Teva Pharmaceutical Industries Ltd. - Key news
	Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key offerings
	Exhibit 167: Teva Pharmaceutical Industries Ltd. - Segment focus
	12.17 Therapyx Inc.
	Exhibit 168: Therapyx Inc. - Overview
	Exhibit 169: Therapyx Inc. - Product / Service
	Exhibit 170: Therapyx Inc. - Key offerings
	13 Appendix
	
	13.1 Scope of the report
	13.2 Inclusions and exclusions checklist
	Exhibit 171: Inclusions checklist
	Exhibit 172: Exclusions checklist
	13.3 Currency conversion rates for US$
	Exhibit 173: Currency conversion rates for US$
	13.4 Research methodology
	Exhibit 174: Research methodology
	Exhibit 175: Validation techniques employed for market sizing
	Exhibit 176: Information sources
	13.5 List of abbreviations
	Exhibit 177: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global gonorrhea therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Therapy - Market share 2022-2027 (%)
Exhibits49: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Therapy
Exhibits51: Data Table on Comparison by Therapy
Exhibits52: Chart on Monotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Monotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Monotherapy - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Monotherapy - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Combination therapy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Combination therapy - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Combination therapy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Combination therapy - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Therapy ($ million)
Exhibits61: Data Table on Market opportunity by Therapy ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Apotex Inc. - Overview
Exhibits112: Apotex Inc. - Product / Service
Exhibits113: Apotex Inc. - Key offerings
Exhibits114: Aurobindo Pharma Ltd. - Overview
Exhibits115: Aurobindo Pharma Ltd. - Product / Service
Exhibits116: Aurobindo Pharma Ltd. - Key offerings
Exhibits117: Bristol Myers Squibb Co. - Overview
Exhibits118: Bristol Myers Squibb Co. - Product / Service
Exhibits119: Bristol Myers Squibb Co. - Key news
Exhibits120: Bristol Myers Squibb Co. - Key offerings
Exhibits121: Cipla Ltd. - Overview
Exhibits122: Cipla Ltd. - Business segments
Exhibits123: Cipla Ltd. - Key news
Exhibits124: Cipla Ltd. - Key offerings
Exhibits125: Cipla Ltd. - Segment focus
Exhibits126: Debiopharm International SA - Overview
Exhibits127: Debiopharm International SA - Product / Service
Exhibits128: Debiopharm International SA - Key news
Exhibits129: Debiopharm International SA - Key offerings
Exhibits130: Entasis Therapeutics - Overview
Exhibits131: Entasis Therapeutics - Product / Service
Exhibits132: Entasis Therapeutics - Key offerings
Exhibits133: F. Hoffmann La Roche Ltd. - Overview
Exhibits134: F. Hoffmann La Roche Ltd. - Business segments
Exhibits135: F. Hoffmann La Roche Ltd. - Key news
Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits138: GlaxoSmithKline Plc - Overview
Exhibits139: GlaxoSmithKline Plc - Business segments
Exhibits140: GlaxoSmithKline Plc - Key news
Exhibits141: GlaxoSmithKline Plc - Key offerings
Exhibits142: GlaxoSmithKline Plc - Segment focus
Exhibits143: Hikma Pharmaceuticals Plc - Overview
Exhibits144: Hikma Pharmaceuticals Plc - Business segments
Exhibits145: Hikma Pharmaceuticals Plc - Key offerings
Exhibits146: Hikma Pharmaceuticals Plc - Segment focus
Exhibits147: Lupin Ltd. - Overview
Exhibits148: Lupin Ltd. - Product / Service
Exhibits149: Lupin Ltd. - Key news
Exhibits150: Lupin Ltd. - Key offerings
Exhibits151: Mayne Pharma Group Ltd. - Overview
Exhibits152: Mayne Pharma Group Ltd. - Business segments
Exhibits153: Mayne Pharma Group Ltd. - Key news
Exhibits154: Mayne Pharma Group Ltd. - Key offerings
Exhibits155: Mayne Pharma Group Ltd. - Segment focus
Exhibits156: Pfizer Inc. - Overview
Exhibits157: Pfizer Inc. - Product / Service
Exhibits158: Pfizer Inc. - Key news
Exhibits159: Pfizer Inc. - Key offerings
Exhibits160: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits161: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits162: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits163: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits164: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits165: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits166: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits167: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits168: Therapyx Inc. - Overview
Exhibits169: Therapyx Inc. - Product / Service
Exhibits170: Therapyx Inc. - Key offerings
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations